MIATNB: A Non-Coding RNA Molecule with Potential as a Drug Target and Biomarker

Target Name: MIATNB

NCBI ID: G102724827

MIATNB

Other Name(s): MIAT neighbor

MIATNB: A Non-Coding RNA Molecule with Potential as a Drug Target and Biomarker

MIATNB, also known as miR-181c, is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer. Its unique structure and function have made it an attractive target for researchers to study, and recent studies have shed new light on its potential in the field of medicine.

MIATNB is a small RNA molecule that is approximately 200 nucleotides in length. It is expressed in various tissues of the body and has been shown to play a role in various biological processes, including cell growth, differentiation, and inflammation. One of its most well-known functions is its role in cell proliferation, as it has been shown to promote the growth and survival of cancer cells.

In addition to its role in cell proliferation, MIATNB has also been shown to play a role in cell death, as it has been shown to induce cell death in various cell types, including cancer cells. This suggests that it may have potential as a drug target for diseases that are characterized by uncontrolled cell growth, such as cancer.

Another potential function of MIATNB is its role in the regulation of inflammation. It has been shown to play a role in the regulation of various immune responses, including the regulation of T cell responses. This suggests that it may have potential as a drug target for diseases that are characterized by chronic inflammation, such as rheumatoid arthritis.

MIATNB has also been shown to play a role in the regulation of cell signaling pathways, including the regulation of the PI3K/Akt signaling pathway. This suggests that it may have potential as a drug target for diseases that are characterized by disruptions in signaling pathways, such as neurodegenerative diseases.

In addition to its potential as a drug target, MIATNB has also been shown to have potential as a biomarker for various diseases. For example, it has been shown to be downregulated in various types of cancer, which suggests that it may be a useful biomarker for cancer diagnosis and treatment. Additionally, it has been shown to be elevated in the blood of individuals with certain neurological diseases, such as Alzheimer's disease, which suggests that it may be a useful biomarker for these diseases as well.

Overall, MIATNB is a fascinating molecule that has a wide range of potential functions as a drug target and biomarker. Its unique structure and function have made it an attractive target for researchers to study, and recent studies have shed new light on its potential in the field of medicine. Further research is needed to fully understand the role of MIATNB in various biological processes and its potential as a drug target and biomarker.

Protein Name: MIAT Neighbor

The "MIATNB Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIATNB comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets